As of Feb 16
| -1.06 / -2.98%|
The 5 analysts offering 12-month price forecasts for Albireo Pharma Inc have a median target of 63.00, with a high estimate of 92.00 and a low estimate of 47.00. The median estimate represents a +82.45% increase from the last price of 34.53.
The current consensus among 6 polled investment analysts is to Buy stock in Albireo Pharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.